Figure 5. Overall survival and progression-free survival in patients stratified according to combination of neutrophil–to–lymphocyte ratio (NLR) and red blood cell distribution width (RDW). (A) The median OS for patients with NLR/RDW score 0, 1, and 2 was 16.2 (95%CI=10.2-not reached), 7.5 (95%CI=2.0-10.8), and 1.9 (95%CI=1.2-not reached) months (p<0.001), respectively. (B) The median PFS for patients with NLR/RDW score 0, 1, and 2 was 5.3 (95%CI=3.9-10.2), 1.7 (95%CI=1.1-6.2), and 1.5 (95%CI=0.4-not reached) months (p=0.033), respectively.